17 results
PRE 14A
AKRO
Akero Therapeutics Inc
16 Apr 24
Preliminary proxy
4:30pm
rules to be included in our annual proxy statement;
reviewing all related person transactions for potential conflict of interest situations
424B5
AKRO
Akero Therapeutics Inc
17 May 23
Prospectus supplement for primary offering
4:45pm
– Underwriting Conflicts from having to provide certain conflict of interest disclosure in this document.
(D) Statutory Rights of Action
Securities
DEF 14A
9pqz1 zzvz
27 Apr 20
Definitive proxy
7:30am
424B4
tehtwfrx
20 Jun 19
Prospectus supplement with pricing info
5:20pm
S-1/A
e5efs rac4zmntbagx1
10 Jun 19
IPO registration (amended)
11:16am
S-1
31szbmc9aq280veq9
24 May 19
IPO registration
4:18pm
S-1
EX-10.9
rswa3zbque
24 May 19
IPO registration
4:18pm
S-1
EX-10.4
5l8cci
24 May 19
IPO registration
4:18pm
DRS/A
kwu7amtyur65
30 Apr 19
Draft registration statement (amended)
12:00am
DRS/A
EX-10.7
7ly7157eeofo 8s9
30 Apr 19
Draft registration statement (amended)
12:00am
DRS/A
4psecwe
19 Mar 19
Draft registration statement (amended)
12:00am
DRS
oscd84
17 Jan 19
Draft registration statement
12:00am
DRS
EX-10.7
riaeojuhx s3wx
17 Jan 19
Draft registration statement
12:00am
- Prev
- 1
- Next